Well.....there's no doubt that the delays that have plagued mesoblast for the past 12 months have provided opportunities for our competitors to establish their market share of the covid cash. Although it's a good thing for more proven treatments to emerge to tackle this insidious virus......I'm so sick of lockdowns that I really don't care now who beats us to the task....however, reading these articles gives one a 'knot in the guts,' when as SH we know what we have, with the data to support it and here we are still jumping through a tunnel of bureaucratic hoops.
New COVID-19 treatment showing early success in Sydney hospitals
Well.....there's no doubt that the delays that have plagued...
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |